Automate Your Wheel Strategy on HYPR
With Tiblio's Option Bot, you can configure your own wheel strategy including HYPR - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol HYPR
- Rev/Share 0.1383
- Book/Share 0.4499
- PB 2.5451
- Debt/Equity 0.0071
- CurrentRatio 5.0195
- ROIC -1.1265
- MktCap 89975244.0
- FreeCF/Share -0.4507
- PFCF -2.5567
- PE -2.2714
- Debt/Assets 0.0055
- DivYield 0
- ROE -0.8482
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 3
- D/E Score 4
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Hyperfine (HYPR) Upgraded to Buy: Here's Why
Published: August 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Hyperfine (HYPR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
Hyperfine Stock Rises After FDA Clears Next-Gen Swoop MRI System
Published: June 03, 2025 by: Zacks Investment Research
Sentiment: Positive
HYPR secures FDA clearance for its next-gen Swoop system, advancing bedside MRI tech and reinforcing its mission to revolutionize accessible neuroimaging.
Read More
HYPR Stock Jumps on NVIDIA Partnership to Advance AI Neuroimaging
Published: March 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Hyperfine partners with NVIDIA to integrate advanced AI into its Swoop MRI system, aiming to transform neuroimaging with faster and more accessible brain scan solutions.
Read More
About Hyperfine, Inc. (HYPR)
- IPO Date 2021-01-28
- Website https://hyperfine.io
- Industry Medical - Devices
- CEO Maria Sainz
- Employees 111